Our tests and services
Our tests and services are all about helping you take control and make decisions about your health. See the three categories below to help guide you to the most appropriate choices for you.
Call us on +44 (0) 1270 623 179 if you would like to talk through the options with one of our specialists.
Am I at risk of hereditary cancer?
Genetic counselling is required when you buy these tests – from your own clinician/healthcare provider or through our specialist service.
All of us have a 1 in 2 lifetime risk of developing cancer, but some are known to occur more frequently in families, passing down the generations. This test analyses 30 genes associated with the most common hereditary cancers.Read more
Making decisions about my cancer treatment
These are tests you can buy with the help of your clinician – we can show you how.
Understanding your likely response or resistance to certain classic chemotherapies and other targeted therapies and immunotherapies is invaluable in planning your treatment. Choose this test if you have Stage IV in Breast HR+/HR2+, Colon, or NSCLC (Non-Small Cell Lung Cancer}.Read more
If you have Stage III of any cancer tumour – or Stage IV in certain conditions, this test can help you identify the best treatment plan for you if. See also our OncoSTRAT&GO test.Read more
This test is about helping you and your clinician determine the best treatment plan for you based on the analysis of your tumour and blood. It looks for the presence of specific biomarkers and can identify how your cancer is likely to respond to classic chemotherapies as well as other targeted therapies and immunotherapies.Read more
Analysing the personal bio-markers in your genes to monitor the effect your drugs or other therapies are having on your cancer is the purpose of this test. It means you can adapt your treatment based on what you learn.Read more
If you have Stage II or Stage III colon cancer, this test can be used to understand the risk of your cancer recurring and therefore enable you make informed decisions about your personal treatment options. It is particularly valuable in assessing whether chemotherapy is necessary or appropriate.Read more
Learn whether PARP inhibitors – one of the latest treatments available – could help you fight ovarian epithelial cancer with this two-gene test focusing on BRCA 1 and BRCA 2.Read more
TumorNext – HRD
Ask about our wider 11-gene test which looks at factors including whether PARP inhibitors – one of the latest treatments available in fighting ovarian epithelial cancer – can help you.Read more
Rapid BRCA 1/2
If you have already been diagnosed with one of the common cancers, this test is a fast track analysis that can help you make vital decisions about your treatment – particularly if you a considering surgical options.Read more